Koyfin Home > Directory > Health Care > Antares Pharma > Enterprise Value

Antares Pharma Enterprise Value Chart (ATRS)

Antares Pharma annual/quarterly Enterprise Value from 2001 to 2018.
  • Antares Pharma Enterprise Value for the quarter ending March 03, 2018 was $338m a -41.44% decrease of -140m year over year
  • Antares Pharma Annual Enterprise Value for 2017 was $299m a -10.16% decrease of -30m from 2016
  • Antares Pharma Annual Enterprise Value for 2016 was $330m a 57.69% increase of 190m from 2015
  • Antares Pharma Annual Enterprise Value for 2015 was $139m a -108.22% decrease of -151m from 2014
Other Valuation Metrics:
  • Antares Pharma Market Cap for the quarter ending March 03, 2018 was $345m a -45.56% decrease of -157m year over year
  • Antares Pharma Price / Book for the quarter ending March 03, 2018 was 10.27 a -17.66% decrease of -1.81 year over year
View Chart On Koyfin

Quarterly ATRS Enterprise Value Data

03/2018$338m
12/2017$299m
09/2017$488m
06/2017$478m
03/2017$413m
12/2016$330m
09/2016$224m
06/2016$121m
03/2016$87m
12/2015$139m

Annual ATRS Enterprise Value Data

2017$299m
2016$330m
2015$139m
2014$290m
2013$501m
2012$447m
2011$202m
2010$132m
2009$78m
2008$15m